Fundraising FoxRascaltherapeutics
1 known investors
Find your way into Rascaltherapeutics
Sign up to see every warm intro you have to Rascaltherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rascaltherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RasCal Therapeutics develops targeted cancer therapies aimed at previously "untargetable" mutations that drive some of the deadliest cancers, using novel mechanisms intended to work alongside conventional treatments, targeted therapies, and immunotherapies. The company is conducting human clinical trials of its lead anti-cancer compound.
Investors · 1
TSVClisted by TSVCSilicon Valley · $1M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Rascaltherapeutics do?
- RasCal Therapeutics develops targeted cancer therapies aimed at previously "untargetable" mutations that drive some of the deadliest cancers, using novel mechanisms intended to work alongside conventional treatments, targeted therapies, and immunotherapies. The company is conducting human clinical trials of its lead anti-cancer compound.
- Who are Rascaltherapeutics's investors?
- Rascaltherapeutics's investors include TSVC.